GSK3B and hepatocellular carcinoma: The inactivation of GSK-3β inhibited the β-catenin degradation and promoted nuclear translocation of β-catenin to initiate the transcription of Zeb1, resulting in HCC cell growth and metastasis (Fig. 6j).